The Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixi
Clinical trial NCT05591391 · UNKNOWN
Trial details
- NCT number
- NCT05591391
- Sponsor
- Taipei Veterans General Hospital, Taiwan
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2025-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.